Since the concentration of p-tau in the CSF 20 attomolar, 1 picomolar in the interstitial fluid, and 1.0 micromolar in the neurons, it would seem quite impossible to expect p-tau at the levels seen in human AD brains to aggregate without a catalyst [30]. The gene discussed is MAPT; the disease is Alzheimer disease.